Today’s Stock Market in 2-Minutes
March 20, 2026
March 20, 2026
March 20, 2026
March 20, 2026
March 20, 2026
Patrick Gruber, CEO of Gevo (NASDAQ: GEVO), shares how the company is pioneering renewable, drop-in hydrocarbon jet fuels that are cost-competitive with traditional petroleum-based alternatives. With over 450 patents and projects backed by a $1.63B DOE loan guarantee, Gevo is scaling commercial production through facilities in South Dakota and North Dakota. The company’s ethanol-based jet fuel, carbon capture, and RNG assets are unlocking significant revenue streams—positioning Gevo to become EBITDA positive in 2025. With $270M+ in cash, strategic partnerships, and bipartisan support for 45Z tax credits, Gevo is accelerating the transition to net-zero aviation fuels.
May 22, 2025Las Vegas, NV, March 16, 2026 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, and Consensus Core Technologies Inc. (“Consensus Core”), today announced the completion of the third set of milestones for the Midwestern and Maritime hyperscale data center campuses operated […]
March 16, 2026
Geneva, Switzerland, March 20, 2026 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that as quantum computing advances toward practical applicability, it is strengthening blockchain and digital transaction infrastructures through the deployment of post-quantum […]
March 20, 2026
Rehovot, Israel, March 20, 2026 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a provider of edge artificial intelligence (“AI”) video and data processing solutions for defense and autonomous platforms, today announced a development milestone in its collaboration with Quantum Gyro Ltd. (“Quantum Gyro”), a company developing next-generation quantum-based gyroscope technology. […]
March 20, 2026
Financing strengthens balance sheet and supports advancement of key development initiatives NEWTON, MA, March 20, 2026 (GLOBE NEWSWIRE) — Bioxytran, Inc. (OTC: BIXT), a clinical-stage biotechnology company focused on developing therapies targeting hypoxia and viral diseases, today announced that it has completed a private placement financing on March 18, 2026, resulting in gross proceeds of […]
March 20, 2026
March 20, 2026
March 20, 2026
March 20, 2026
March 20, 2026
March 20, 2026
March 20, 2026
March 20, 2026
March 20, 2026